AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.4310
-0.0090 (-2.05%)
At close: Feb 26, 2026

AccuStem Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
75715--
Market Cap Growth
74.43%-28.40%-53.62%---
Enterprise Value
75712--
Last Close Price
0.430.450.631.35--
PB Ratio
-2.38-1.53-3.36-109.68--
Debt / Equity Ratio
-0.01-0.01-0.03-0.76--
Net Debt / Equity Ratio
-0.01-0.01-0.024.50--
Net Debt / EBITDA Ratio
-0.02-0.01-0.020.17--
Net Debt / FCF Ratio
-0.04-0.03-0.020.35--
Quick Ratio
0.000.000.010.681.9324.66
Current Ratio
0.350.020.060.861.9324.66
Return on Equity (ROE)
----1465.96%-68.41%-
Return on Assets (ROA)
-120.28%-1018.35%-238.76%-204.23%-30.84%-
Return on Capital Employed (ROCE)
55.40%45.40%97.10%2684.60%-103.10%-7.10%
Earnings Yield
-23.30%-29.61%-28.88%-24.48%--
FCF Yield
--13.06%-22.76%-11.87%--
Buyback Yield / Dilution
-24.61%-0.78%-3.00%-10.17%--
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.